Back to search

Article

Use of human AML cells to study graft-versus-leukemia immunity in xenogeneic mouse models of GVHD

2024-05-02

Abstract excerpt

Allogeneic hematopoietic cell transplantation (allo-HCT) is the main therapeutic approach for patients with high-risk acute myeloid leukemia (AML), but the rate of relapse remains high and is associated with poor outcomes. Discovering new approaches to maximize the graft-versus-leukemia (GVL) effects while mitigating graft-versus-host disease (GVHD) should therefore be pursued. Because of the difficulties in model...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
76aa8e8a-5692-5d5a-9804-63118a29d382
DOI
10.1101/2024.04.30.591828
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Use of human AML cells to study graft-versus-leukemia immunity in xenogeneic mouse models of GVHDDOI 10.1101/2024.04.30.591828
Select a neighboring publication to make it the new centre.